Jared S. Iverson


Iverson, Jared

Jared Iverson's practice focuses on all aspects of corporate law. He represents public and private companies in a variety of industries, including technology, life sciences and financial services.

Prior to joining the firm, Mr. Iverson was a legal extern with the Boston University Office of the General Counsel, and was a summer associate in WilmerHale's Boston office in 2014. He also interned with the City of Waltham Law Department, where he researched and worked on a variety of municipal law issues including government, ethics, civil rights, property and labor and employment. While in law school, Mr. Iverson served as a notes editor for the Boston University Law Review.

Mr. Iverson is an accomplished trumpet player, and has performed and taught throughout New England. He has performed for numerous community and charitable events and is an advocate for music education. Mr. Iverson has received commendation for his performances, including an award for a solo performance at a United States Navy 9/11 Memorial service.

Publications & News


October 26, 2017

WilmerHale Serves as Counsel to Idera Pharmaceuticals in Public Offering of Common Stock

Idera Pharmaceuticals, Inc. announced the pricing of its underwritten public offering of 33,333,334 shares of its common stock at a public offering price of $1.50 per share.

July 11, 2017

Staples, Inc. Enters Into Definitive Agreement to Be Acquired by Sycamore Partners for $10.25 per Share in Cash, or Approximately $6.9 Billion

Staples, Inc. and Sycamore Partners, a leading private equity firm, announced that they have entered into a merger agreement in which investment funds managed by Sycamore Partners will acquire Staples in a transaction that values Staples at an equity value of approximately $6.9 billion.

April 5, 2017

WilmerHale Counsels Reflexis to Accelerate Growth With Investment From Great Hill Partners

Reflexis, the leader in retail real-time execution and workforce management solutions, announced that it has received a minority equity investment from Great Hill Partners.

April 4, 2017

AVEO Announces Closing of Public Offering and Full Exercise of Option to Purchase Additional Shares

WilmerHale client AVEO Pharmaceuticals, Inc. announced the closing of its previously announced underwritten public offering of 34,500,000 shares of common stock.

July 20, 2016

WilmerHale Advises Aushon BioSystems in $6.14M Series C Financing

Aushon BioSystems, a global provider of protein biomarker measurement and analysis products and services via an innovative, cost-effective multiplex immunoassay platform, announced that it held the initial closing of a $6.14 million Series C Financing.

March 24, 2016

2016 M&A Report

Our 2016 M&A Report offers a detailed review of, and outlook for, the global M&A market. Other highlights include a comparison of deal terms in public and private acquisitions; updates on takeover defenses and public company deal litigation; practical guidance on avoiding antitrust violations in pre-merger integration planning; a look at what buyers need to know about appraisal claims in private company mergers; and a survey of key terms and issues in sales of VC-backed companies.


Skip Navigation Links.


JD, cum laude, Boston University School of Law, 2015, Notes Editor, Boston University Law Review

BMus, summa cum laude, University of Massachusetts, Amherst, 2008

Bar Admissions


Skip Navigation Links.